Shoddy biopsies deny cancer patients a shot at personalized treatment
Elie Dolgin • January 22, 2016
A huge federal trial of personalized cancer medicine has run into an unexpected roadblock: Many of the tumor samples aren’t robust enough to be put through genetic analysis.
Continue reading at
STAT.
Jaw-dropping patient videos and miraculous testimonials ignited a frenzy in China over a technique that aims to improve drainage from the brain. Now it is entering trials worldwide.
But politics could derail the one thing to unlock it.